Q2 revenue increased 23% year-over-year to a record $163 million driven by robust marketplace growth.Q2 marketplace revenue increased 26% year-over-year driven by strong enterprise growth and expandin ...

Second quarter 2025 net product revenue from global sales of IMCIVREE® (setmelanotide) of $48.5 million ---- U.S. and EU ...

Aggregate net proceeds expected to fund SL-325 through multiple Phase 2 clinical trials, including in Inflammatory Bowel Disease (IBD) and potentially another autoimmune disease – – Pro forma cash and ...

Second-quarter payoffs totaled approximately $150 million, mainly due to open market property sales. Loan Pipeline-- Pipeline exceeded $2.1 billion, a slight increase over the first quarter's ending ...

Scent and memories are closely linked and smelling something familiar can instantly trigger an emotional response and remind you of a specific moment or time. But, when the scent appears out of ...

About 67,400 Americans will be diagnosed with the highly aggressive disease this year, and nearly 52,000 will die from it, ...

Merger creates a market-leading North American provider of Testing, Inspection, Certification and Compliance (TICC) and Engineering Services - Expands ability to deliver complementary services to ...

2025 full-year revenue guidance -- Revenue is now expected to be between $1.645 billion and $1.655 billion for 2025. 2025 ...

Overall, Palantir is an innovative AI company that offers nuanced and optimized solutions derived from the world's most complex datasets. The company is deeply ingrained within diverse end markets and ...

Edison International's preferred stock offers a projected 17% annualized return. Read here for more analysis on Edison's ...

During its Q2 2025 earnings call on July 31, Strategy (MSTR) announced that it will no longer issue its MSTR common stock at ...

MIAMI, FL / ACCESS Newswire / July 30, 2025 / Safe & Green Holdings Corp. (NASDAQ:SGBX) (“Safe & Green” or the “Company”), a ...